{"version":"1.0","type":"link","title":"Venetoclax plus hypomethylating agents versus priming regimen as the first-line therapy for newly diagnosed acute myeloid leukemia with myelodysplasia-related changes: a propensity score-matched analysis.","author_name":"Huang YH 외","author_url":"https://prs-insight.online/author/Huang%20YH","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/165393","thumbnail_width":1200,"thumbnail_height":630}